Vivanza Biosciences Ltd
08 May 2026 12:00 AM
Vivanza Biosciences reports consolidated net loss of Rs 0.45 crore in the March 2026 quarter,
Net Loss of Vivanza Biosciences reported to Rs 0.45 crore in the quarter ended March 2026 as against net loss of Rs 1.00 crore during the previous quarter ended March 2025. Sales rose 1225.00% to Rs 6.36 crore in the quarter ended March 2026 as against Rs 0.48 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.67 crore during the previous year ended March 2025. Sales rose 1462.13% to Rs 115.91 crore in the year ended March 2026 as against Rs 7.42 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.360.48 1225 115.917.42 1462 OPM %-3.62-200.00 -0.63-4.85 - PBDT-0.29-0.99 71 0.57-0.65 LP PBT-0.30-0.99 70 0.54-0.67 LP NP-0.45-1.00 55 0.39-0.67 LP Powered by Capital Market - Live News
Vivanza Biosciences Ltd
29 Apr 2026 12:00 AM
Vivanza Biosciences to table results,
Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 4 May 2026.
Vivanza Biosciences Ltd
12 Feb 2026 12:00 AM
Vivanza Biosciences consolidated net profit rises 400.00% in the December 2025 quarter,
Net profit of Vivanza Biosciences rose 400.00% to Rs 0.20 crore in the quarter ended December 2025 as against Rs 0.04 crore during the previous quarter ended December 2024. Sales rose 2916.67% to Rs 45.25 crore in the quarter ended December 2025 as against Rs 1.50 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales45.251.50 2917 OPM %0.468.00 - PBDT0.200.05 300 PBT0.200.04 400 NP0.200.04 400 Powered by Capital Market - Live News
Vivanza Biosciences Ltd
06 Feb 2026 12:00 AM
Vivanza Biosciences to announce Quarterly Result,
Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News
Vivanza Biosciences Ltd
12 Nov 2025 12:00 AM
Vivanza Biosciences consolidated net profit rises 2700.00% in the September 2025 quarter,
Net profit of Vivanza Biosciences rose 2700.00% to Rs 0.56 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 1745.33% to Rs 55.36 crore in the quarter ended September 2025 as against Rs 3.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales55.363.00 1745 OPM %1.083.67 - PBDT0.570.02 2750 PBT0.560.02 2700 NP0.560.02 2700 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
HSL Mobile App